Xenon Pharmaceuticals (XENE) Tax Provisions (2018 - 2026)
Xenon Pharmaceuticals (XENE) reported Tax Provisions of -$2.6 million for Q1 2026, down 702.11% year-over-year from $427000.0 in Q1 2025, and down 168.82% quarter-over-quarter from $3.7 million in Q4 2025.
Xenon Pharmaceuticals (XENE) Tax Provisions (2018 - 2026) Analysis & Trends
Xenon Pharmaceuticals (XENE) has 9 years of Tax Provisions data on file, last reported at -$2.6 million in Q1 2026.
- Tax Provisions for Q1 2026 came in at -$2.6 million, down 702.11% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.2 million (up 129.85% YoY), and the FY2025 annual result was $4.2 million, up 203.06% from the prior year.
- Tax Provisions slipped to -$2.6 million in Q1 2026 per XENE's latest filing, from $3.7 million in the prior quarter.
- Over five years, Tax Provisions peaked at $3.7 million in Q4 2025 and troughed at -$3.8 million in Q4 2024.
- A 5-year average of -$154117.6 and a median of -$205000.0 in 2023 frame the typical range for Tax Provisions.
- The sharpest annual moves came in 2024 and 2025: Tax Provisions sank 1777.07% in 2024, then surged 311.56% in 2025.
- A 5-year view of Tax Provisions shows it stood at $1.1 million in 2022, then plunged by 118.0% to -$205000.0 in 2023, then slumped by 1777.07% to -$3.8 million in 2024, then jumped by 197.09% to $3.7 million in 2025, then slumped by 168.82% to -$2.6 million in 2026.
- Business Quant data shows XENE's Tax Provisions at -$2.6 million in Q1 2026, $3.7 million in Q4 2025, and $677000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 216,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Xenon Pharmaceuticals | 4.61 Bn | 4.61 Bn | - | -2.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.57 Mn |
| Dec 31, 2025 | 3.74 Mn |
| Sep 30, 2025 | 677,000.00 |
| Jun 30, 2025 | -626,000.00 |
| Mar 31, 2025 | 427,000.00 |
| Dec 31, 2024 | -3.85 Mn |
| Sep 30, 2024 | -320,000.00 |
| Jun 30, 2024 | -333,000.00 |
| Mar 31, 2024 | 412,000.00 |
| Dec 31, 2023 | -205,000.00 |
| Sep 30, 2023 | -157,000.00 |
| Jun 30, 2023 | -220,000.00 |
| Mar 31, 2023 | 290,000.00 |
| Dec 31, 2022 | 1.14 Mn |
| Sep 30, 2022 | -587,000.00 |
| Jun 30, 2022 | -40,000.00 |
| Mar 31, 2022 | -394,000.00 |
| Dec 31, 2021 | 484,000.00 |
| Sep 30, 2021 | -205,000.00 |
| Jun 30, 2021 | -217,000.00 |